Automated cancer diagnostics
World models are the hottest race in AI right now. Every frontier lab is building one - but they're all aimed at robotics, generalist agents, autonomous vehicles. None at oncology. We're the first.
Nucleo automates target versus non-target lesion classification according to RECIST standards, streamlining the workflow for oncology trials and treatment response assessment.
Nucleo provides automated tumor lesion sizing with high agreement to expert standards, eliminating manual measurement variability and ensuring reproducible quantification for treatment monitoring and RECIST criteria compliance.
Nucleo automates CT scan analysis for cancer diagnostics, delivering results in seconds instead of hours through AI-powered segmentation and measurement, enabling faster clinical decision-making in oncology workflows.
Nucleo automatically detects and quantifies fat and muscle mass in CT scans, enabling rapid body composition assessment for sarcopenia evaluation without manual segmentation.